Neuropathic Pain After Dental Implant Surgery: Literature Review and Proposed Algorithm for Medicosurgical Treatment.


Journal

The Journal of oral implantology
ISSN: 0160-6972
Titre abrégé: J Oral Implantol
Pays: United States
ID NLM: 7801086

Informations de publication

Date de publication:
01 04 2023
Historique:
medline: 20 4 2023
pubmed: 17 2 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

The objective of this study is to establish an algorithm for the medicosurgical treatment of dental implant-induced neuropathic pain. The methodology was based on the good practice guidelines from the French National Authority for Health: the data were searched on the Medline database. A working group has drawn up a first draft of professional recommendations corresponding to a set of qualitative summaries. Consecutive drafts were amended by the members of an interdisciplinary reading committee. A total of 91 publications were screened, of which 26 were selected to establish the recommendations: 1 randomized clinical trial, 3 controlled cohort studies, 13 case series, and 9 case reports. In the event of the occurrence of post-implant neuropathic pain, a thorough radiological assessment by at least a panoramic radiograph (orthopantomogram) or especially a cone-beam computerized tomography scan is recommended to ensure that the tip of the implant is placed more than 4 mm from the anterior loop of the mental nerve for an anterior implant and 2 mm from the inferior alveolar nerve for a posterior implant. Very early administration of high-dose steroids, possibly associated with partial unscrewing or full removal of the implant preferably within the first 36-48 hours after placement, is recommended. A combined pharmacological therapy (anticonvulsants, antidepressants) could minimize the risk of pain chronicization. If a nerve lesion occurs in the context of dental implant surgery, treatment should be initiated within the first 36-48 hours after implant placement, including partial or full removal of the implant and early pharmacological treatment.

Identifiants

pubmed: 36796060
pii: 490897
doi: 10.1563/aaid-joi-D-21-00200
doi:

Substances chimiques

Dental Implants 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Pagination

218-227

Auteurs

Alp Alantar (A)

Oral Surgery Unit, Max Fourestier Hospital, Nanterre, France.

Jacques-Christian Béatrix (JC)

Centre Hospitalier Sud Seine-et-Marne, Site de Nemours, Nemours, France.

Guy Marti (G)

Maxillofacial Surgery Unit, Clinique Saint-Jean, L'Ermitage Hospital, Melun, France and Johns Hopkins University School of Medicine, Baltimore, USA.

Guy Princ (G)

Oral and Maxillofacial Surgery in private practice, Paris, France.

Nathalie Rei (N)

Department of Stomatology, Faculty of Dentistry, University of Montréal, Québec, Canada.

Patrick Missika (P)

Department of Oral Surgery, Faculty of Dentistry, University Paris-Diderot, Paris, France and Department of Oral Surgery, Tufts University School of Dental Medicine, Boston, Massachusetts, USA.

Pierre Cesaro (P)

Department of Neurology, Henri Mondor University Hospital, APHP, Créteil, France.

Jean-Pascal Lefaucheur (JP)

Faculty of Medicine, University Paris-Est-Créteil and Clinical Neurophysiology Unit, Henri Mondor University Hospital, APHP, Créteil, France.

Marc Sorel (M)

Faculty of Medicine, University Paris-Est-Créteil and Pain Center, Centre Hospitalier Sud Seine-et-Marne, Nemours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH